Roche Diagnostics

Roche Diagnostics is one of the world’s largest providers of in vitro diagnostics (IVD), molecular diagnostics, pathology solutions, and digital healthcare technologies. As a division of Roche, the company is headquartered in Rotkreuz, Switzerland, and serves hospitals, clinical laboratories, physicians, and research institutions in more than 100 countries. Roche Diagnostics plays a vital role in improving patient care by enabling accurate disease detection, early diagnosis, and personalized treatment decisions.

The company offers one of the industry’s most comprehensive diagnostics portfolios, including clinical chemistry, immunoassays, molecular diagnostics (PCR), next-generation sequencing (NGS) solutions, tissue diagnostics, diabetes care systems, digital pathology, laboratory automation, and point-of-care testing. Roche Diagnostics is particularly recognized for its cobas® systems, Ventana pathology solutions, and advanced oncology diagnostics that support precision medicine.

Roche invests billions of dollars annually in research and development, integrating artificial intelligence, automation, cloud-based laboratory management, and genomic technologies into modern healthcare. Its manufacturing facilities and research centers comply with stringent international quality standards and are regulated by agencies including the US FDA, European IVDR, ISO, and numerous national health authorities.

With decades of scientific innovation and global healthcare leadership, Roche Diagnostics continues to shape the future of laboratory medicine, helping healthcare professionals deliver faster diagnoses, better treatment decisions, and improved patient outcomes worldwide.